TY - JOUR
T1 - Targeting prolonged short-term central venous catheters to reduce hospital-wide catheter days and CLABSI rates
AU - Cohen, Regev
AU - Lipman-Arens, Shelly
AU - Mahamid, Lamis
AU - Ishay, Linor
AU - Feld Simon, Olga
AU - Reisfeld, Sharon
AU - Ben-Natan, Orna
AU - Vaknin, Aliza
AU - Ganayem, Mohammed
AU - Abu Hadba, Razi
AU - Karisi, Erez
AU - Melnik, Noa
AU - Freimann, Sarit
AU - Shapira, Maanit
AU - Avshovich, Nina
AU - Darawshe, Ayed
AU - Rachmilevitch, Ronit
AU - Istomin, Valery
AU - Abilevitch, Rena
AU - Abu-Mouch, Saif
AU - Novoselsky, Rotem
AU - Beckerman, Marinella
AU - Dubinchik, Vlada
AU - Kessel, Boris
AU - Zilbermints, Veacheslav
AU - Starobinsky, Veronika
AU - Furman, Inna
AU - Neimark, Konstantin
AU - Daskal, Yaakov
AU - Ganayem, Mohanad
AU - Biton, Fanny
AU - Isakovich, Boris
AU - Tannous, Elias
N1 - Publisher Copyright:
© 2024 Association for Professionals in Infection Control and Epidemiology, Inc.
PY - 2025/3/1
Y1 - 2025/3/1
N2 - Background: The risk of central line-associated bloodstream infection (CLABSI) is associated with central venous catheter (CVC) dwelling time. We implemented a hospital-wide intervention aimed to alert physicians to CVC duration and necessity and to improve the monitoring of CLABSI prevention process measures outside the intensive care unit (ICU). Methods: A retrospective, before-after study that evaluated short-term, nonhemodialysis CVCs in and out of the ICU. The intervention included enhanced bundle-prevention measures monitoring and staff “sensitization” regarding prolonged (> 7 days) CVCs (pCVCs). The ICU intervention also included daily CVC-stewardship visits. We assessed CVC utilizations and CLABSI episodes 20 months before to 19 months after the intervention using Mann-Whitney tests. Results: Out of the ICU, CVC-utilization ratio (CVC-UR) and pCVC-UR reduced significantly (4.1-2.7/100 hospital days, P = .005; and 28%-21%, P = .02, respectively). Bundle-prevention measures improved, and CLABSI rates reduced postintervention (7.9-3.6/1,000 CVC days, P = .03). In the ICU, pCVC-UR reduced significantly (29%-15%, P < .0001). Baseline ICU-CLABSI rates were low and did not reduce postintervention. Conclusions: Sensitizing physicians to the existence and duration of CVCs accompanied by improved bundle-prevention measures, resulted in reduction of pCVCs, and outside the ICU, also in reduction of CVC-UR and CLABSI rates.
AB - Background: The risk of central line-associated bloodstream infection (CLABSI) is associated with central venous catheter (CVC) dwelling time. We implemented a hospital-wide intervention aimed to alert physicians to CVC duration and necessity and to improve the monitoring of CLABSI prevention process measures outside the intensive care unit (ICU). Methods: A retrospective, before-after study that evaluated short-term, nonhemodialysis CVCs in and out of the ICU. The intervention included enhanced bundle-prevention measures monitoring and staff “sensitization” regarding prolonged (> 7 days) CVCs (pCVCs). The ICU intervention also included daily CVC-stewardship visits. We assessed CVC utilizations and CLABSI episodes 20 months before to 19 months after the intervention using Mann-Whitney tests. Results: Out of the ICU, CVC-utilization ratio (CVC-UR) and pCVC-UR reduced significantly (4.1-2.7/100 hospital days, P = .005; and 28%-21%, P = .02, respectively). Bundle-prevention measures improved, and CLABSI rates reduced postintervention (7.9-3.6/1,000 CVC days, P = .03). In the ICU, pCVC-UR reduced significantly (29%-15%, P < .0001). Baseline ICU-CLABSI rates were low and did not reduce postintervention. Conclusions: Sensitizing physicians to the existence and duration of CVCs accompanied by improved bundle-prevention measures, resulted in reduction of pCVCs, and outside the ICU, also in reduction of CVC-UR and CLABSI rates.
KW - Bundle
KW - Catheter duration
KW - Catheter related bloodstream infection
KW - Idle catheter
KW - Utilization ratio
UR - http://www.scopus.com/inward/record.url?scp=85208411953&partnerID=8YFLogxK
U2 - 10.1016/j.ajic.2024.10.011
DO - 10.1016/j.ajic.2024.10.011
M3 - Article
C2 - 39427926
AN - SCOPUS:85208411953
SN - 0196-6553
VL - 53
SP - 361
EP - 367
JO - American Journal of Infection Control
JF - American Journal of Infection Control
IS - 3
ER -